Skip to main content

EDITORIAL article

Front. Med., 04 May 2022
Sec. Nephrology
This article is part of the Research Topic Molecular Mechanism and Therapeutic Approach to Renal Interstitial Fibrosis View all 7 articles

Editorial: Molecular Mechanism and Therapeutic Approach to Renal Interstitial Fibrosis

\nMao-Ting LiMao-Ting Li1Xiao-Han TangXiao-Han Tang2Hui CaiHui Cai3Ai-Hua ZhangAi-Hua Zhang4Zhi-Yong Guo
Zhi-Yong Guo1*
  • 1Department of Nephrology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, China
  • 2Department of Pharmacology, Weill Cornell Medical College of Cornell University, New York, NY, United States
  • 3School of Medicine, Emory University, Atlanta, GA, United States
  • 4Nanjing Children's Hospital, Nanjing, China

Renal interstitial fibrosis (RIF) refers to the abnormal deposition of collagen and related proteins in the interstitium of renal cortex, it is a common histological abnormality in all types of renal diseases (1). We have made great strides in the molecular mechanisms and treatment of RIF through a series of explorations.

Epithelial-mesenchymal transition (EMT) is an important initiation link of RIF and previous studies have suggested that EMT has an important role in renal tissue damage repair (2). In nephrolithiasis or crystallize-induced renal injury, EMT occurs in renal tubular epithelial cells at the initial stage of nephrolithiasis formation or the stage of crystallize-induced renal injury, then triggering the process of renal fibrosis (3). Long non-coding RNA (lncRNAs), which are a type of non-coding RNAs, have been shown its importance in the process of organ fibrosis (4). Hu et al. noted that lncRNA SPANXA2OT1 could adsorb miR-204 through sponge-like action, thereby attenuating the inhibitory effect of miR-204 on Smad5 and upregulating Smad5 expression, and is involved in the occurrence and development of EMT in renal tubular epithelial cells. In diabetic kidney disease (DKD), Wang et al. noted that JMJD1A/NR4A1 signaling can regulate the advanced glycation end products (AGEs)-induce EMT in renal tubular epithelial cells. AGEs cause oxidative stress, trigger excessive reactive oxygen species, and promote the production and release of inflammatory cytokines (5). Their continuous stimulation usually causes damage to HK-2 cells in renal tubular epithelial cells, and lead to extracellular matrix (ECM) deposition and abnormal synthesis and degradation of epithelial proteins, further causing epithelial-mesenchymal transition (EMT) and even interstitial fibrosis (6). Overexpression of JMJD1A accelerates the progression of AGEs-induced renal fibrosis by reducing the expression of NR4A1 in HK-2 cells. NR4A1 is closely related to renal fibrosis, and contributes to the occurrence and development of DKD. Therefore, NR4A1 inhibitors could promote the expression of fibrosis-related factors such as VIM, a-SMA in HK-2 cells, and aggravate the process of fibrosis.

In addition to molecular mechanisms, subsequent studies are gradually inclined to clinical. Some important protein molecules have been excavated, which will help to predict the occurrence and development of RIF. Ou et al. noted that the occurrence of RIF may be involved in immune response and related pathways. Plasma Galectin-3 (Gal-3), a multifunctional glycan-binding protein, is widely expressed in immune cells, especially in monocytes/macrophages, which profoundly affect critical macrophage functions, such as phagocytosis and phenotype transition (7, 8). In fibrotic kidney biopsy samples, the level of Gal-3 is upregulated and the differentially expressed genes are mainly enhanced in immune cell activation and the regulation of cell-cell adhesion. Moreover, Gal-3 knockout mice exhibit a decrease in collagen accumulation and resistance to the development of fibrosis in an in vivo model (9). Therefore, Gal-3 was suggested to be used as a predictive marker of RIF to identify individuals at risk for renal fibrosis at the earliest possible stage, so as to slow down or even reverse the renal function.

In addition, renal fibrosis is the pathological repair reaction of kidney to chronic injury and is the important process of chronic kidney disease (CKD) progressing to end-stage renal disease (ESRD). Over recent years, obstructive nephropathy caused by urinary calculi has become one of the common factors of CKD. The research related to the treatment and prognosis of RIF is worthy of further exploration. Calcium oxalate (CaOx) is the major component of most kidney stones, which has become the focus of RIF naturally, which can interact with renal tubular epithelial cells and induce oxidative stress and inflammation (10). Excessive oxidative stress and inflammation not only enhance the deposition and retention of CaOx crystals in tubular cells, but also result in the development of fibrosis (11). Therefore, revealing the mechanism of crystalline kidney injury can provide potential targets and pathways for the intervention of renal calculi, and more importantly, provide guidance for the early prevention and treatment of renal calculi and reduce the risk of renal failure. Gao et al. suggested that CaOx crystal could induce inflammatory reaction and oxidative stress through Akt, ERK1/2, and P38 MAPK pathways and affect amino acid metabolism and fatty acids β oxidation, resulting in kidney injury. Besides, according to a series of studies on the treatment of crystalline kidney injury, hydrogen-rich water (HRW), which has been used in the medical field, attracted our attention due to its activities of anti-oxidation, anti-inflammation, anti-fibrosis, and anti-apoptosis (12). The primary advantages of HRW are that it is a portable, easily administered, and safe means of delivering hydrogen. Si et al. noted that HRW administration could alleviate oxidative stress induced by oxalate diet via decreasing the content of MDA, ROS and increase the levels of SOD, GSH-Px and CAT via inhibiting PI3K/AKT, NF-κB pathways. In dependently from this, HRW can ameliorate oxalate-induce renal fibrosis via inhibiting the TGF-β/Smad signaling pathway.

RIF is considered to be a key predictor of renal functional recovery and prognosis in most renal diseases (1). At present, renal biopsy is the gold standard for evaluating RIF. However, due to the extreme shortcomings, its invasiveness, low reproducibility, and the limited size of the collected sample, this approach has not been widely implemented in the clinic (13). Therefore, there is an urgent clinical need for a method for non-invasively evaluating the degree of renal fibrosis. chronic glomerulonephritis (CGN) remains the leading cause of CKD and ESRD in China currently (14). Wu et al. noted that native T1 mapping, a quantitative magnetic resonance imaging (MRI) technique that has been reported to reflect the degree of tissue fibrosis in CGN patients, might serve as an alternative approach to kidney biopsy for detecting renal fibrosis. These is a good correlation between the T1 value and traditional clinical indirect indicators for the evaluation of renal fibrosis, such as SCr, NGAL, CysC, Hb, renal length, eGFR and Hct.

Author Contributions

M-TL: writing—original draft preparation. Z-YG: writing—review and editing. X-HT, HC, and A-HZ: supervision. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. (2020) 16:269–88. doi: 10.1038/s41581-019-0248-y

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. (2003) 112:1776–84. doi: 10.1172/JCI200320530

CrossRef Full Text | Google Scholar

3. Hu H, Chen W, Ding J, Jia M, Yin J, Guo Z. Fasudil prevents calcium oxalate crystal deposit and renal fibrogenesis in glyoxylate-induced nephrolithic mice. Exp Mol Pathol. (2015) 98:277–85. doi: 10.1016/j.yexmp.2015.02.006

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Huang C, Yang Y, Liu L. Interaction of long noncoding RNAs and microRNAs in the pathogenesis of idiopathic pulmonary fibrosis. Physiol Genomics. (2015) 47:463–9. doi: 10.1152/physiolgenomics.00064.2015

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Kopytek M, Zabczyk M, Mazur P, Undas A, Natorska J. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardiovasc Diabetol. (2020) 19:92. doi: 10.1186/s12933-020-01068-7

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Sun Y, Ge X, Li X, He J, Wei X, Du J, et al. High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction. Cell Death Dis. (2020) 11:914. doi: 10.1038/s41419-020-03122-4

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Díaz-Alvarez L, Ortega E. The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens. Mediators Inflamm. (2017) 2017:9247574. doi: 10.1155/2017/9247574

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C, Iredale JP, et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol. (2008) 172:288–98. doi: 10.2353/ajpath.2008.070726

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Calvier L, Martinez-Martinez E, Miana M, Cachofeiro V, Rousseau E, Sádaba JR, et al. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC Heart Fail. (2015) 3:59–67. doi: 10.1016/j.jchf.2014.08.002

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Khan SR, Canales BK, Dominguez-Gutierrez PR. Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation. Nat Rev Nephrol. (2021) 17:417–33. doi: 10.1038/s41581-020-00392-1

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Khan SR. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol. (2014) 3:256–76. doi: 10.3978/j.issn.2223-4683.2014.06.04

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Huang CS, Kawamura T, Toyoda Y, Nakao A. Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res. (2010) 44:971–82. doi: 10.3109/10715762.2010.500328

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Luciano RL, Moeckel GW. Update on the native kidney biopsy: core curriculum 2019. Am J Kidney Dis. (2019) 73:404–15. doi: 10.1053/j.ajkd.2018.10.011

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Xie J, Chen N. Primary glomerulonephritis in mainland China: an overview. Contrib Nephrol. (2013) 181:1–11. doi: 10.1159/000348642

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: epithelial-mesenchymal transition, lncRNA SPANXA2OT1, galectin-3, hydrogen-rich water, native T1 mapping, signal pathway

Citation: Li M-T, Tang X-H, Cai H, Zhang A-H and Guo Z-Y (2022) Editorial: Molecular Mechanism and Therapeutic Approach to Renal Interstitial Fibrosis. Front. Med. 9:879927. doi: 10.3389/fmed.2022.879927

Received: 20 February 2022; Accepted: 13 April 2022;
Published: 04 May 2022.

Edited and reviewed by: Minnie M. Sarwal, University of California, San Francisco, United States

Copyright © 2022 Li, Tang, Cai, Zhang and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhi-Yong Guo, drguozhiyong@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.